ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rebif 44, Injektionslösung in Fertigspritzen - 12 Spritze(n)
54810064 Merck (Schweiz) AG
Rebif 44, Injektionslösung in Fertigspritzen23.12.1998
  10.10.2008
Interferon Beta-1a (L03AB07)20.12.2006
WHO-DDD 
01.99.12 Spritze(n)
01.99. 
B  
Yes 
IPCI
1002.33No
    
10 %1161.95
7680548100641Biotechnologika
4062400 
Composition
interferonum beta-1a ADNr 44 µg corresp. 12 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Interferonum Beta-1a Adnr44 µg
BAG: Active AgentDose
Interferonum Beta-1a Adnr44 mcg
 
Inactive agentsDose
Acetic Acid 
Alcohol Benzylicus2.5 mg
Mannitol 
Methionine 
Sodium Acetate Trihydrate 
Sodium Hydroxide 
Poloxamer188
 
Source
Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home